MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/j.1468-1293.2004.00231.x

Медицинская библиотека · HIV medicine · 2004

Recent changes in the management of primary HIV-1 infection: results from the French PRIMO cohort.

Schiffer V, Deveau C, Meyer L, Iraqui I, Nguyen-Wartel A, Chaix M-L, Delfraissy J-F, Rouzioux C, Venet A, Goujard C, French PRIMO Cohort Study Group

Сравнительное исследованиеСтатьяМногоцентровое исследованиеПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

OBJECTIVES

To describe the management of primary HIV infection (PHI), focusing on changes in the design of therapies and time to initiation of antiretroviral treatment, the clinical outcome, and the immuno-virological response over time to highly active antiretroviral therapy (HAART) and its tolerance.

DESIGN AND

METHODS

In the French PRIMO multicentre cohort, 291 patients presenting with PHI were enrolled between 1996 and 2001. Data were analysed to describe treatment prescription habits over a period of 5 years, and response to and tolerance of treatment.

RESULTS

The proportion of patients who initiated treatment during PHI decreased from 92% in 1996 to 56% in 2001. At 6 months, whatever the initiated treatment, 74% of treated patients achieved a plasma viral load<400 HIV-1 RNA copies/mL and 53% achieved a viral load of<50 copies/mL. Prescription of protease inhibitor (PI)-sparing regimens has become more frequent since 1999. Despite a similar virological response, patients in the PI-containing group tended to experience a greater 1-year increase in CD4 cell count than those in the non-nucleoside reverse transcriptase (NNRTI)-containing group (218 cells/microL versus 157 cells/microL, respectively). An adverse event was recorded in 51% of treated patients. The most frequent events were gastrointestinal disorders (71%), lipodystrophy (27%) and mood disorders (19%). The main reason for modifying or stopping therapy was the occurrence of an adverse event.

CONCLUSIONS

Limitations of therapy and poor tolerance to antiretroviral regimens have changed physician attitudes in PHI. This suggests the need for evaluation of better-tolerated regimens and new therapeutic strategies.

Для цитирования: Schiffer V, Deveau C, Meyer L, Iraqui I, Nguyen-Wartel A, Chaix M-L, Delfraissy J-F, Rouzioux C, Venet A, Goujard C, French PRIMO Cohort Study Group. Recent changes in the management of primary HIV-1 infection: results from the French PRIMO cohort.. HIV medicine. 2004. DOI: 10.1111/j.1468-1293.2004.00231.x.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.